Standard BioTools (LAB) vs Quantum-Si (QSI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Quantum-Si (QSI) has outperformed Standard BioTools (LAB) over the past year, losing 27.7% versus a loss of 47.8%. Over five years, QSI leads with a -85.1% price change compared with -87.3% for LAB. Quantum-Si is the larger company by market cap ($266.9 million vs $259.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LAB | QSI |
|---|---|---|
| Share price | $0.6617 | $1.22 |
| Market cap | $259.77M | $266.86M |
| 1-day change | -2.51% | -4.75% |
| YTD return | -46.98% | +16.36% |
| 1-year return | -47.79% | -27.68% |
| 5-year return | -87.29% | -85.12% |
| EPS (TTM) | $-0.13 | $-0.45 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.72 | $3.10 |
| 52-week low | $0.63 | $0.69 |
| Distance from 52-week high | -61.53% | -60.67% |
| Analyst consensus | none | buy |
| Avg. price target upside | +104.02% | +87.01% |
| Average volume | 1.57M | 4.10M |
| Shares outstanding | 392.58M | 198.95M |
| Employees | 385 | 145 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Industrial Machinery/Components |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- QSI has outperformed LAB by 20.1 percentage points over the past year.
About Standard BioTools
LAB stock →Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments.
Industrials · Biotechnology: Laboratory Analytical Instruments · 385 employees
About Quantum-Si
QSI stock →Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS.
Industrials · Industrial Machinery/Components · 145 employees
LAB vs QSI FAQ
Which is bigger, Standard BioTools or Quantum-Si?
Quantum-Si (QSI) is larger, with a market capitalization of $266.86M compared with $259.77M for Standard BioTools (LAB).
Which stock has performed better over the past year, LAB or QSI?
QSI returned -27.68% over the past 12 months, compared with -47.79% for LAB (price return, excluding dividends). Past performance does not predict future results.
Are Standard BioTools and Quantum-Si in the same industry?
Both are in the Industrials sector, but in different industries: Biotechnology: Laboratory Analytical Instruments for Standard BioTools and Industrial Machinery/Components for Quantum-Si.